Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models
Lorenzo Melchor(BMW (Germany)), Matthew J. Smalley(Cardiff University), Gemma Molyneux(Institute of Cancer Research), Alan Mackay(Institute of Cancer Research), Jorge S. Reis‐Filho(AstraZeneca (France)), Daniel Nava Rodrigues(Institute of Cancer Research), M. Atienza(Instituto de Biomedicina de Sevilla), Howard Kendrick(Institute of Cancer Research), José Palacios(Universidad de Alcalá), David Robertson(Institute of Cancer Research), Fiona‐Ann Magnay(Institute of Cancer Research), Fernanda Milanezi(Universidade do Porto), María Ángeles López‐García(Guy's Hospital), Kirsty R. Greenow(Cardiff University)
Cited by 59
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
|Cancer Cell|2017|1.3k
<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
|New England Journal of Medicine|2012|1k